The reduction of GSSG is catalyzed by GSH reductase (GR), utilizing NADPH in the process
Mounjaro and Constipation: What Real Users Are Saying About Digestive Slowdown While Mounjaro (tirzepatide) has gained popularity for its weight loss and appetite-suppressing effects, many users are discovering an unwelcome side effect: constipation
The fuller your stomach, the more likely it is to push upward
UK considerations NHS and MHRA guidance The UK health authorities have clear positions on weight loss treatments: The NHS offers GLP-1 medications through specialist weight management services for eligible patients MHRA has approved Wegovy, Saxenda, and Mounjaro based on comprehensive safety and efficacy data No GLP-1 patch products have received MHRA approval as weight loss treatments The MHRA has issued warnings about misleading claims in weight loss supplements Cost and access in the UK The financial aspect is a significant consideration for many: NHS provision : Limited availability through specialist weight management services with strict eligibility criteria Private prescriptions : 150-300 monthly, depending on medication and provider Commercial patches : 12-70 monthly, depending on brand and quantity While patches appear less expensive, they lack evidence of effectiveness, making them poor value regardless of price
No research chemicals, no guesswork
Several studies point to a protective role of GLP-1RAs on retinal pigment epithelium (RPE) cells, which form the blood-retinal barrier and are vulnerable to inflammation [83, 84]